R. M. Cohen
Islet autoimmunity is highly prevalent and associated with diminished β-cell function in patients with type 2 diabetes in the Grade Study
Rationale and design for a GRADE substudy of continuous glucose monitoring
Diabetes Technology & Therapeutics.
Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
Diabetes, Obesity & Metabolism.
Effects of TZD use and discontinuation on fracture rates in ACCORD Bone Study
Journal of Clinical Endocrinology and Metabolism.
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Lancet (London, England).
Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]
Map of science